These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17335328)

  • 1. Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
    Van Ameringen M; Mancini C; Oakman J; Walker J; Kjernisted K; Chokka P; Johnston D; Bennett M; Patterson B
    J Clin Psychiatry; 2007 Feb; 68(2):288-95. PubMed ID: 17335328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nefazodone in social phobia.
    Van Ameringen M; Mancini C; Oakman JM
    J Clin Psychiatry; 1999 Feb; 60(2):96-100. PubMed ID: 10084635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nefazodone for social phobia: a clinical case series.
    Worthington JJ; Zucker BG; Fones CS; Otto MW; Pollack MH
    Depress Anxiety; 1998; 8(3):131-3. PubMed ID: 9836065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
    Stein MB; Liebowitz MR; Lydiard RB; Pitts CD; Bushnell W; Gergel I
    JAMA; 1998 Aug; 280(8):708-13. PubMed ID: 9728642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.
    Stein DJ; Berk M; Els C; Emsley RA; Gittelson L; Wilson D; Oakes R; Hunter B
    S Afr Med J; 1999 Apr; 89(4):402-6. PubMed ID: 10341825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
    Baldwin D; Bobes J; Stein DJ; Scharwächter I; Faure M
    Br J Psychiatry; 1999 Aug; 175():120-6. PubMed ID: 10627793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.
    Mancini C; Van Ameringen M; Oakman JM; Farvolden P
    Depress Anxiety; 1999; 10(1):33-9. PubMed ID: 10499188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.
    Asakura S; Tajima O; Koyama T
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):263-74. PubMed ID: 16573847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response in generalized social phobia: effect of age of onset.
    Van Ameringen M; Oakman J; Mancini C; Pipe B; Chung H
    J Clin Psychopharmacol; 2004 Feb; 24(1):42-8. PubMed ID: 14709946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open trial of topiramate in the treatment of generalized social phobia.
    Van Ameringen M; Mancini C; Pipe B; Oakman J; Bennett M
    J Clin Psychiatry; 2004 Dec; 65(12):1674-8. PubMed ID: 15641873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.
    Stein MB; Chartier MJ; Hazen AL; Kroft CD; Chale RA; Coté D; Walker JR
    J Clin Psychopharmacol; 1996 Jun; 16(3):218-22. PubMed ID: 8784653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
    Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ; Trivedi MH; Rush AJ; Thase ME; Howland R; Klein DN; Kornstein SG; Dunner DL; Markowitz JC; Hirschfeld RM; Keitner GI; Zajecka J; Kocsis JH; Russell JM; Miller I; Manber R; Arnow B; Rothbaum B; Munsaka M; Banks P; Borian FE; Keller MB
    Biol Psychiatry; 2003 Oct; 54(8):806-17. PubMed ID: 14550680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.
    Stein MB; Sareen J; Hami S; Chao J
    Am J Psychiatry; 2001 Oct; 158(10):1725-7. PubMed ID: 11579011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie YJ; Nandy S; Pecknold JC; Hadrava V; Lane RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.